RxDoctor Payments Data

Marissa Kehrwald

Family · Excelsior Springs, MONPI 1487285946

Payments from drug & device makers

$3,749in general payments, 2019–2025

Across 250 payments — averaging $15.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$479
  • Pfizer$287
  • AstraZeneca$234
  • Novo Nordisk$185
  • Takeda Pharmaceuticals U.S.A., Inc.$144
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$3,749100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,749 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$14,693
Stiolto RespimatTiotropium Br/Olodaterol Hcl19$9,168
Albuterol Sulfate HfaAlbuterol Sulfate68$1,395
Omeprazole49$1,169
Betamethasone Dipropionate11$1,147
Atorvastatin Calcium76$1,059
Bupropion XlBupropion Hcl23$831
Ventolin HfaAlbuterol Sulfate12$705
Gabapentin29$565
Lisinopril58$523
Montelukast Sodium38$449
Losartan Potassium43$431
ClopidogrelClopidogrel Bisulfate20$393
Rosuvastatin Calcium25$378
Famotidine24$373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$16$14,69318 claims
Boehringer IngelheimStiolto Respimat$40$9,16819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.

Other family in Excelsior Springs

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →